期刊文献+

银杏叶注射液对慢性阻塞性肺疾病患者D-二聚体和抗凝血酶Ⅲ水平的影响 被引量:2

Study on the influence of plasma D-dimer and antithrombin Ⅲ levels in Yinxingye injection in patients with acute exacerbations of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的 探讨利用银杏叶注射液辅助治疗慢性阻塞性肺疾病急性加重期(AECOPD)患者的外周血D-二聚体(D-dimer,DD)和抗凝血酶Ⅲ(ATⅢ)变化及其临床意义。方法分别于入院时、治疗后2周抽取42例AECOPD患者静脉血并测定其血浆DD和ATⅢ水平,与健康对照组比较,并将AECOPD分为传统治疗组(A组)和银杏叶治疗组(B组),比较两组治疗后2周DD和ATⅢ水平的变化。结果42例AECOPD患者入院时DD(584.4±193.8)μg/L高于32名对照组(190.3±101.9)μg/L,入院时ATⅢ(76.29±11.72)%低于对照组(90.70±7.05)%,差异有统计学意义(P〈0.01);两组治疗前DD水平和ATⅢ差异无统计学意义(P〉0.05);传统治疗组21例治疗2周DD降至(421.9±156.2)μg/L,ATⅢ升高至(83.10±8.32)Voo;银杏叶治疗组21例降至(302.5±166.0)μg/L,ATⅢ升高至(88.79±9.32)%;治疗后DD水平均较治疗前有所下降,ATIⅢ水平均较治疗前有所升高,差异均有统计学意义(P值均〈0.05);银杏叶治疗组在治疗后的DD水平比传统治疗组明显减低,银杏叶治疗组在治疗后ATⅢ水平比传统治疗组明显升高,差异有统计学意义(P值均〈0.05)。结论银杏叶注射液能明显降低DD,显著增加ATⅢ,对AECOPD有一定的治疗价值,与AECOPD的预后有关。 Objective To investigate the changes and clinic significance of plasma D-dimer (DD) and antithrombin (ATⅢ) levels in Yinxingye injection in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Methods The plasma levels of DD and ATⅢ were detected before and after 2 weeks of treatment in 42 patients with AECOPD and 32 healthy persons as control subjects. The patients were divided into group of ordinary therapy (group A) and group of Yinxingye injection (group B). The plasma levels of DD and AT Ⅲ were compared before and after treatment between the groups. Results Before treatment, the level of DD (584.4±193.8) /,g/L was significantly higher in 42 patients of AECOPD than in control subjects (190.3±101.9) /,g/L, the level of AT lll (76.29± 11.72) ~ was significantly lower than that in control subjects (90.70±7.05) % there was significant statistical difference between the two groups of AECOPD and control subjects (P〈 0.01). There was no significant statistical difference the levels of DD and ATⅢ between group A and group B ( P〈0.05). In group A, the levels of DD decreased to (421.9± 156.2) μg/L and ATⅢ increased to (83. 10±8. 32) % after 2 weeks of therapy ( P〈0.05). In group B, DD decreased to (302.5±166.0) μg/L and AT HI increased to (88.79± 9.32) % after 2 weeks of therapy ( P 〈0.05). There was significant statistical difference in the lower DD and the higher ATⅢ between before treatment and after therapy ( P 〈0.05). After therapy ,the level of DD in group B was significantly lower than that of group A, and the level of ATⅢ in group B was significantly higher than that of group A. There was significant statistical difference between group B and group A after therapy ( P 〈0.05). Conclusions There was significant lower in the level of DD and significant higher in the level of AT Ⅲ after the therapy of Yinxingye injection in patients with AECOPD ,which were also related to the outcome of AECOPD.
出处 《国际呼吸杂志》 2012年第1期26-29,共4页 International Journal of Respiration
关键词 银杏叶注射液 慢性阻塞性 肺疾病 D-二聚体 抗凝血酶Ⅲ Yinxingye injection Chronic ol:,structive Pulmonary disease D-dimer Antithombin Ⅲ
  • 相关文献

参考文献10

  • 1张旻,周新,张杏怡,丁星.慢性阻塞性肺病稳定期的下呼吸道细菌定植研究[J].微生物与感染,2006,1(2):99-102. 被引量:14
  • 2Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 2003, 107:1514-1519.
  • 3Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma ddimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest, 2004, 126: 1087- 1092.
  • 4Shorr AF, Trotta RF, predicts mortality in Alkins SA, et coagulati al. D-dimer assay patients without thromboembolic disease. Intensive Care Med, 1999,25:207 210.
  • 5中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,:8-17.
  • 6Levi M, van der Poll T, Baller HR. Bidirectional relation between inflammation and coagulation. Circulation, 2004, 109 : 2698-2704.
  • 7Taguchi O, Gabazza EC, Yasui H, et al. Prognostic significance of plasma D-dimer levels in patients with lungcancer. Thorax, 1997,52 : 563-565.
  • 8Parent F, Maitre S, Meyer C,et al. Diagnostic wtlue of ATⅢ in patients with chronic obstructive pulmonary disease: results from a muhicentre outcome study. Thromb Res, 2009,120:195-200.
  • 9Fan PS, C-u ZI., Sheng R,et al. Inhibitory effect of quercetin on proliferation of human microvaseular endothelial cells in vitro. Acta Pharmacol Sin,2003,24: 1231-1234.
  • 10龚晓健,李运曼,卞惠敏,方伟蓉,刘国卿.银杏总内酯抗血小板聚集与抗血栓作用[J].中国临床药理学与治疗学,2006,11(7):822-825. 被引量:39

二级参考文献21

  • 1秦兵,张根葆,陈冬云,许敏,李爱华.银杏内酯B对脑缺血-再灌注神经元损伤的保护作用[J].中国中西医结合急救杂志,2005,12(1):17-20. 被引量:36
  • 2任俊,贾正平,邓虹珠,何晓英,张汝学,李琳.银杏内酯对三种脑缺血模型大鼠的保护作用[J].中药新药与临床药理,2005,16(1):41-45. 被引量:16
  • 3Monso E, Rosell A, Boner G, et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J, 1999, 13:338 - 342
  • 4Tom M, Wilkinson A,Iren S, et al. Airway Bacterial local and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Repir Crit Care Meal,2003,167:1090 - 1095
  • 5Stockley RA, O' Brien C, Pye A, et al. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest,2001,117:1638 - 1645
  • 6Noguera A, Battles S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax,2001,56:432 - 437
  • 7Chung KF. Cytokines in chronic obstructive pulmonary disease.Eur Respir J, 2001,18 : 50 - 59
  • 8Pauwels RA, Buist .AS, Calverley PM, et al. GOLD: the global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001,46 : 798 - 825
  • 9Adams SG, Melo J, Luthe M, et al. Antibiotics are associated with lower relapse rates in ontpatients with acute exacerbatios of COPD. Chest. 2000, 117:1345 - 1352
  • 10Aaron SD, Angel JB. Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive puhnonary disease. Am J Respir Crit Care Med 2001,163:349 - 355

共引文献51

同被引文献15

  • 1Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis: an overview [J]. Clin Med Insights Oncol, 2014, 8: 129-137.
  • 2Coady K, Ali M, Sidloff D, et al. A oomparison of inftiorrs and com- plicallorrs in central venous catheters in adults with solid tumou[J]. J Vasc Access, 2015, 16(1): 38-41.
  • 3Ay C, Dunkler D, Pirker R, et al. High D-dimer levels are asso- ciated with poor prognosis in cancer patients [J]. Haematologica, 2012, 97(8): 1158-1164.
  • 4Komurcuoglu B, Ulusoy S, Gayaf M, et al. Prognostic value of plasma D-dimer levels in lung carcinoma [J]. Tumori, 2011, 97(6): 743-748.
  • 5Marinho FC, Takagaki TY. Hypercoagulability and lung cancer [J]. J Bras Pneumol, 2008,34(5): 312-322.
  • 6Gil-Bazo I, P 6 ramo JA, Garc t a-Foncillas J. New prognostic and predictive factors in advanced colorectal cancer [J]. Med Clin (Barc), 2006, 126(14): 541-548.
  • 7Burris HA 3rd. Low-molecular-weight heparins in the treat- ment of cancer-associated thrombosis: a new standard of care? [J]. Semin Oncol, 2006, 33(2 Suppl 4):S3-16; quiz S41-42.
  • 8Zacharski LR, Lee AY. Heparin as an anticancer therapeu- tic [J]. Expert Opin Investig Drugs, 2008, 17(7): 1029-1037.
  • 9YUAN Guang-jin,KE Qin-hua,XU Xi-ming,YANG Ji-yuan,SU Xiao-yan.Gefitinib-induced disseminated intravascular coagulation in a patient with non-small cell lung cancer[J].Chinese Medical Journal,2010(4):505-506. 被引量:2
  • 10郜靓,张亚雷,杨海虹.晚期非小细胞肺癌血浆纤维蛋白原、D-二聚体及血小板水平与预后的相关性研究[J].安徽医药,2010,14(11):1311-1312. 被引量:14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部